BOEING CO/THE (BCO.DE) Stock Fundamental Analysis
Europe - FRA:BCO - US0970231058 - Common Stock
168.48 EUR
+0.44 (+0.26%)
We assign a fundamental rating of 1 out of 10 to BCO. BCO was compared to 46 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of BCO have multiple concerns. BCO is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BCO has reported negative net income.
BCO had a negative operating cash flow in the past year.
BCO had negative earnings in each of the past 5 years.
In multiple years BCO reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of BCO (-6.78%) is worse than 89.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.78% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of BCO (1.10%) is worse than 91.30% of its industry peers.
BCO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.1% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BCO has more shares outstanding
Compared to 5 years ago, BCO has more shares outstanding
Compared to 1 year ago, BCO has an improved debt to assets ratio.
2.2 Solvency
BCO has an Altman-Z score of 1.15. This is a bad value and indicates that BCO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BCO (1.15) is worse than 82.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.15 |
ROIC/WACCN/A
WACC9.08%
2.3 Liquidity
BCO has a Current Ratio of 1.18. This is a normal value and indicates that BCO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.18, BCO is in line with its industry, outperforming 56.52% of the companies in the same industry.
BCO has a Quick Ratio of 1.18. This is a bad value and indicates that BCO is not financially healthy enough and could expect problems in meeting its short term obligations.
BCO's Quick ratio of 0.38 is on the low side compared to the rest of the industry. BCO is outperformed by 91.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.38 |
3. Growth
3.1 Past
BCO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.07%.
BCO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.18%.
BCO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.74% yearly.
EPS 1Y (TTM)-1.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.45%
Revenue 1Y (TTM)10.18%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%30.44%
3.2 Future
The Earnings Per Share is expected to grow by 20.94% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.15% on average over the next years. This is quite good.
EPS Next Y57.77%
EPS Next 2Y45.81%
EPS Next 3Y31.93%
EPS Next 5Y20.94%
Revenue Next Year30.02%
Revenue Next 2Y20.01%
Revenue Next 3Y17.45%
Revenue Next 5Y14.15%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BCO. In the last year negative earnings were reported.
BCO is valuated quite expensively with a Price/Forward Earnings ratio of 76.00.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BCO indicates a slightly more expensive valuation: BCO is more expensive than 78.26% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.43. BCO is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 76 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BCO's earnings are expected to grow with 31.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.81%
EPS Next 3Y31.93%
5. Dividend
5.1 Amount
No dividends for BCO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BCO (11/12/2025, 7:00:00 PM)
168.48
+0.44 (+0.26%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners74.41%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap127.40B
Revenue(TTM)80.76B
Net Income(TTM)-10.17B
Analysts82.86
Price Target224.57 (33.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.63%
Min EPS beat(2)-57.93%
Max EPS beat(2)18.67%
EPS beat(4)2
Avg EPS beat(4)-16.78%
Min EPS beat(4)-91.07%
Max EPS beat(4)63.2%
EPS beat(8)5
Avg EPS beat(8)-3.37%
EPS beat(12)6
Avg EPS beat(12)-66.45%
EPS beat(16)6
Avg EPS beat(16)-757.66%
Revenue beat(2)2
Avg Revenue beat(2)1.97%
Min Revenue beat(2)1.11%
Max Revenue beat(2)2.82%
Revenue beat(4)2
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)2.82%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)4
Avg Revenue beat(12)-1.59%
Revenue beat(16)4
Avg Revenue beat(16)-4.27%
PT rev (1m)-1.38%
PT rev (3m)6.38%
EPS NQ rev (1m)-532.92%
EPS NQ rev (3m)-305.29%
EPS NY rev (1m)-252.15%
EPS NY rev (3m)-374.34%
Revenue NQ rev (1m)-0.42%
Revenue NQ rev (3m)-0.83%
Revenue NY rev (1m)1.65%
Revenue NY rev (3m)3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 76 | ||
| P/S | 1.83 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-13.05
EYN/A
EPS(NY)2.22
Fwd EY1.32%
FCF(TTM)-7.26
FCFYN/A
OCF(TTM)-4.25
OCFYN/A
SpS92.27
BVpS-9.43
TBVpS-19.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.78% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.1% | ||
| FCFM | N/A |
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 136.76% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.38 | ||
| Altman-Z | 1.15 |
F-Score4
WACC9.08%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.45%
EPS Next Y57.77%
EPS Next 2Y45.81%
EPS Next 3Y31.93%
EPS Next 5Y20.94%
Revenue 1Y (TTM)10.18%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%30.44%
Revenue Next Year30.02%
Revenue Next 2Y20.01%
Revenue Next 3Y17.45%
Revenue Next 5Y14.15%
EBIT growth 1Y-25.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.25%
EBIT Next 3Y49.38%
EBIT Next 5Y32.37%
FCF growth 1Y-237.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-161.56%
OCF growth 3YN/A
OCF growth 5YN/A
BOEING CO/THE / BCO.DE FAQ
What is the fundamental rating for BCO stock?
ChartMill assigns a fundamental rating of 1 / 10 to BCO.DE.
What is the valuation status of BOEING CO/THE (BCO.DE) stock?
ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BCO.DE). This can be considered as Overvalued.
How profitable is BOEING CO/THE (BCO.DE) stock?
BOEING CO/THE (BCO.DE) has a profitability rating of 0 / 10.
What is the expected EPS growth for BOEING CO/THE (BCO.DE) stock?
The Earnings per Share (EPS) of BOEING CO/THE (BCO.DE) is expected to grow by 57.77% in the next year.